Page 5 - Bjdx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and Beyond Air (NASDAQ:XAIR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Institutional and Insider Ownership 45.4% of Bluejay Diagnostics shares […]

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership. Profitability This table compares Bluejay Diagnostics and INVO Bioscience’s […]

Wall Street analysts forecast that Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) will report earnings per share of ($0.08) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Bluejay Diagnostics’ earnings. The firm is expected to report its next earnings results on Monday, January 1st. On average, analysts expect that […]

Brokerages expect Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) to post ($0.08) earnings per share (EPS) for the current quarter, according to Zacks. Zero analysts have made estimates for Bluejay Diagnostics’ earnings. The company is expected to issue its next quarterly earnings report on Monday, January 1st. According to Zacks, analysts expect that Bluejay Diagnostics […]

Zacks Investment Research upgraded shares of Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) from a hold rating to a buy rating in a report released on Monday morning, Zacks.com reports. Zacks Investment Research currently has $1.25 target price on the stock. According to Zacks, “Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused […]